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Abstract: The development of ionizing radiation applications for Industrial 
purposes in Portugal began near of 1982 with the support of IAEA. 
The main steps to put forward prior to the implementation were 
the sitting and the design study in order to build up the facility. 
Subsequently, the main parameters to be achieved were the 
construction, the commissioning, the operation, the maintenance 
and the foreseen decommission.
Once a quality system for the gamma facility was established, the 
following stage is to develop, validate and control the sterilization/
disinfection process. The research activities carried out in the UTR 
have been closely related with the main applications of this technology 
namely, the sterilization of medical devices and pharmaceuticals and 
other products’ decontamination. 
Recently, a research Cobalt-60 equipment was upgraded and 
a LINAC was implemented in order to sustain the R&D. 
Fundamental and development research is ongoing  in order 
to understand the irradiation mechanisms of action and 
to apply the technology with safety and quality patterns.  
Keywords — gamma radiation, Radiosterilization technology, dose, 
IAEA.
Introduction
The development of applications of ionizing radiation for Industrial purposes 
in Portugal began near of 1982 with the support of IAEA under the program of 
Cooperation and Technical Assistance - project POR/8/002.
The IAEA program of Cooperation and Technical Assistance allowed the above 
referred project to take place between 1983 and 1988 with success. The collaboration 
of the International Experts and the personnel of National Laboratory of Industrial 
Engineering and Technology, nowadays Nuclear and Technologic Institute (ITN), 
allowed the construction of a Cobalt-60 irradiation plant, designed by Tecnabexport 
(Russia). This facility is located in the ITN campus at Sacavém, Portugal [1].
The main parameters studied prior to the implementation (sitting, design, construction, 
commissioning, operation, maintenance and foreseen decommission) were planned 
 IT-11
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and executed according with the Portuguese legislation [2] which is based on the 
International rules (IAEA Safety series [3], [4]) and Directive EURATOM 836/80, 
nowadays EURATOM n.º 1493/93.
A study of the geological stability of the site for the future placement of the irradiation 
facility was done prior to the construction. This action could prevent futures 
accidents caused by, for instance, an earthquake. The facility was constructed under 
Portuguese responsibility but designed and loaded with Cobalt-60 by the Russian 
business organization Technabexport between 1987 and 1988. The whole process was 
supervised and approved by the ITN’s Nuclear Protection and Safety Department. 
The initial activity from the cobalt-60 planar irradiator was 1.1x1016 Bq (295 kCi) 
in November 1981. Dosimetry commissioning of the Cobalt-60 was done by dose 
mapping the irradiation chamber, the irradiation process and the irradiator [5] . 
The Cobalt-60 irradiation facility was initially named GammaPi and later on 
Radiation Technologies Unit (UTR) and its management was under ITN’s authority 
until 2003. During this period, several technical upgrading were made, aiming to 
improve the radiological safety and the running process. In this context a Berthold® 
monitoring system, physical barriers (sliding door), and sensors on critical points 
of the sterilization process and software were implemented for the process control 
and monitoring. An automation and robotic system specially designed to place the 
product boxes in the irradiation chamber was also put into operation.
Once a quality system for the gamma facility was established, the following stage is 
to develop, validate and control the sterilization/disinfection process. In this step, 
a multidisciplinary approach and a continuous dialog with product managers and 
personnel must be taken into consideration in the experimental design for the correct 
and effective establishment of irradiation process. The knowledge of product’s 
elements (raw material, personnel and equipment) and line production stages are 
important factors to the safety and quality of the irradiated product.
The research activities carried out in the UTR have been closely related with the 
main applications of this technology, namely the sterilization of medical devices 
and pharmaceuticals and other products’ decontamination. These activities have 
frequently been followed through by industries. These circumstances have lead 
to an increased interest of the industrial sector to gamma radiation sterilization 
processes. In 2003, ITN started a joint venture with a business organization - CHIP, 
S.A. (Hygienization Centrum by Ionization of Products), where ITN turned over the 
management and the exploitation right of UTR to CHIP, S.A.
An experimental Cobalt-60 source was recently upgraded and a LINAC was 
implemented in order to sustain the research and development of ionizing radiation 
application in new materials, art, wastewater and others ﬁeld. Studies in simulation 
based on Monte Carlo programs are being developed in order to optimize the 
irradiation geometry for its technological application. 
Implementation and development of UTR
In Figure 1, a view of the facility and the inside layout are represented.
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Fig. 1. The cobalt-60 facility, named Radiation Technologies Unit (UTR). Outside building 
and inside layout.
One of the main issues in this kind of facilities is the radiation protection systems and 
the reliability of the process.  Several radiation security protection systems must be 
implemented and must function independently from one another, in order to avoid 
a global risk. The main initial systems were mechanical and photoelectrical beams. 
Nevertheless, to improve this ﬁeld and the running process, several equipments 
were put into action in 1995 [6]. In this context, a Berthold® monitoring system, 
physical barriers as sliding doors, sensors on critical points and a process and control 
monitoring software were applied. It was also put into operation an automation 
and robotic system specially designed to place the product boxes in the irradiation 
chamber.
Since 2003, with the business organization by CHIP, S.A. (Hygienization Centrum 
by Ionization of Products) a new approach was carried out.
Under the new management, an upgrading of the activity to 1.02x1016 Bq (276 kCi) 
of the cobalt-60 was done. The whole re-charging of the source was made following 
IAEA requirements and National legislation [7], [8], [9], [10], [11]. The transportation 
of the Cobalt-60 was made in safe containers following all the recommendations 
and requirements for nuclear substances transportation. A special designed pool 
was constructed for the re-charging operations. The Cobalt sources were retrieved 
in a basket inside the pool. As UTR has a dry pit for cobalt source storage, the cobalt 
for the re-charging was transported inside by special containers. All operations and 
procedures performed by the supplier were supervised and documented by ITN’s 
Nuclear Protection and Safety department [12].
CHIP, S.A. underwent an approval process for attaining the licensing to run the 
facility. The approval process aims to establish radiation protection safety and 
Products), where ITN turned over the management and the
exploitation right of UTR to CHIP, S.A.
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operation an automation and robotic s stem specially
designed to plac the product boxes in the irradiation chamber.
Since 2003, with the business organization by CHIP,
S.A. (Hygienization Centrum by Ionization of Products) a new
approach was carried out.
Under the new management, an upgrading of the
activity to 1.02x1016 Bq (276 kCi) of the cobalt-60 was done.
The whole re-charging of the source was made following
IAEA requirements and National legislation [7], [8], [9], [10],
[11]. The transportation of the Cobalt-60 was made in safe
containers following all the recommendations and
requirements for nuclear substances transportation. A special
designed pool was constructed for the re-charging operations.
The Cobalt sources were retrieved in a basket inside the pool.
As UTR has a dry pit for cobalt source storage, the cobalt for
the re-charging was transported inside by special containers.
All operations and procedures performed by the supplier were
supervised and documented by ITN’s Nuclear Protection and
Safety department [12].
CHIP, S.A. underwent an approval process for
attaining the licensing to run the facility. The approval process
aims to establish radiation protection safety and procedures
and has to demonstrate the effective fulfilment of the Quality
Assurance (QA) requirements that accomplish the
prerequisites of the authorities. In order to attain the licensing,
the UTR’s sitting, design, construction, commissioning, safety,
operation, maintenance and decommissioning (within the
supplier’s contract) were reviewed.
The UTR was licensed in July 2004 after the
establishment of the main steps of QA. This re-qualification
process consisted mainly in repeating part of the validation
with the purpose of confirming the continued acceptability of
the specific irradiation process. Dose mapping, dose mapping
recording, calibration of the dosimetric system, operating and
safety procedures, technical specifications, training
qualification and emergency response planning were
evaluated as part of the re-qualification of the UTR. To assure
the Installation Qualification (IQ) it was demonstrated that the
irradiator was supplied and installed in accordance with its
specifications. Figure 2 shows part of documentation of the
new configuration of the racks and isodose curves near the
planar irradiator.
Fig. 2. Cobalt-60 sources distribution in the irradiator and respective activity
(Ci) (left) and isodose curves (right).
The Operational Qualification (OQ) was achieved by
demonstrating that the irradiator was/is capable of operating
and delivering appropriate dose within the defined accepted
criteria. Both qualifications were attained by dose distribution
determination through dose mapping exercises and relating
them with the process parameters. The Performance
Qualification (PQ) was acquired by obtaining evidence and
documenting that the equipment consistently performs in
accordance with predetermined criteria and thereby yields
results meeting its specifications, as installed and operated in
accordance with operational procedures.
b)
c)
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procedures and has to demonstrate the effective fulﬁlment of the Quality Assurance 
(QA) requirements that accomplish the prerequisites of the authorities. In order to 
attain the licensing, the UTR’s sitting, design, construction, commissioning, safety, 
operation, maintenance and decommissioning (within the supplier’s contract) were 
reviewed.
The UTR was licensed in July 2004 after the establishment of the main steps of QA. 
This re-qualiﬁcation process consisted mainly in repeating part of the validation 
with the purpose of conﬁrming the continued acceptability of the speciﬁc irradiation 
process. Dose mapping, dose mapping recording, calibration of the dosimetric system, 
operating and safety procedures, technical speciﬁcations, training qualiﬁcation and 
emergency response planning were evaluated as part of the re-qualiﬁcation of the UTR. 
To assure the Installation Qualiﬁcation (IQ) it was demonstrated that the irradiator 
was supplied and installed in accordance with its speciﬁcations. Figure 2 shows part 
of documentation of the new conﬁguration of the racks and isodose curves near the 
planar irradiator.
Products), where ITN turned over the management and the
exploitation right of UTR to CHIP, S.A.
An experimental Cobalt-60 source was recently upgraded
and a LINAC was implemented in order to sustain the
research and development of ionizing radiation application in
new materials, art, wastewater and others field. Studies in
simulation based on Monte Carlo programs are being
developed in order to optimize the irradiation geometry for its
technological application.
II. IMPLEMENTATION AND DEVELOPMENT OF UTR
In Figure 1, a view of the facility and the inside layout are
represented.
Fig. 1. The cobalt-60 facility, named Radiation Technologies Unit (UTR).
Outside building and inside layout.
One of the main issues in this kind of facilities is the
radiation protection systems and the reliability of the process.
Several radiation security protection systems must be
implemented and must function independently from one
another, in order to avoid a global risk. The main initial
systems were mechanical and photoelectrical beams.
Nevertheless, to improve this field and the running process,
several equipments were put into action in 1995 [6]. In this
context, a Berthold® monitoring system, physical barriers as
sliding doors, sensors on critical points and a process and
control monitoring software were applied. It was also put into
operation an automation and robotic system specially
designed to place the product boxes in the irradiation chamber.
Since 2003, with the business organization by CHIP,
S.A. (Hygienization Centrum by Ionization of Products) a new
approach was carried out.
Under the new management, an upgrading of the
activity to 1.02x1016 Bq (276 kCi) of the cobalt-60 was done.
The whole re-charging of the source was made following
IAEA requirements and National legislation [7], [8], [9], [10],
[11]. The transportation of the Cobalt-60 was made in safe
containers following all the recommendations and
requirements for nuclear substances transportation. A special
designed pool was constructed for the re-charging operations.
The Cobalt sources were retrieved in a basket inside the pool.
As UTR has a dry pit for cobalt source storage, the cobalt for
the re-charging was transported inside by special containers.
All operations and procedures performed by the supplier were
supervised and documented by ITN’s Nuclear Protection and
Safety department [12].
CHIP, S.A. underwent an approval process for
attaining the licensing to run the facility. The approval process
aims to establish radiation protection safety and procedures
and has to demonstrate the effective fulfilment of the Quality
Assurance (QA) requirements that accomplish the
prerequisites of the authorities. In order to attain the licensing,
the UTR’s sitting, design, construction, commissioning, safety,
operation, maintenance and decommissioning (within the
supplier’s contract) were reviewed.
The UTR wa lic nsed in July 2004 after the
establishment of the main st ps of QA. This re-qualification
process consisted mainly in repeating part of the validati
with the purpose of confirming the continued acceptability of
the specific irradiation process. Dose mapping, dose mapping
recording, calibration of the dosimetric system, operating and
safety procedures, technical specifications, training
qualification and emergency response planning were
evaluated as part of the re-qualification of the UTR. To assure
the Installation Qualification (IQ) it was demonstrated that the
irradiator was supplied and installed in accordance with its
specifications. Figure 2 shows part of documentation of the
new configuration of the racks and isodose curves near the
pl nar irradiator.
Fig. 2. Cobalt-60 sources distribution in the irradiator and respective activity
(Ci) (left) and isodose curves (right).
The Operational Qualification (OQ) was achieved by
demonstrating that the irradiator was/is capable of operating
and delivering appropriate dose within the defined accepted
criteria. Both qualifications were attained by dose distribution
determination through dose mapping exercises and relating
them with the process parameters. The Performance
Qualification (PQ) was acquired by obtaining evidence and
documenting that the equipment consistently performs in
accordance with predetermined criteria and thereby yields
results meeting its specifications, as installed and operated in
accordance with operational procedures.
b)
c)
Fig. 2. Cobalt-60 sources distribution in the irradiator and respective activity (Ci) (left) and 
isodose curves (right).
The Operational Qualiﬁcation (OQ) was achieved by demonstrating that the irradiator 
was/is capable of operating a d deliver ng appropriate dose within the deﬁned 
accepted crit ria. Both qualiﬁca ions were attained by dose distribution determination 
through dose mapping exercises and relating them with the process parameters. The 
Performan e Qualiﬁca ion (PQ) was acquired by obtaining evidence and documenting 
that t  equipment consistently perf rms in accordance with predetermined criteria 
an  thereby yields results meeting its speciﬁcations, as installed and operated in 
accordance with operational procedures.
Licensing UTR has brought the attention to Quality issues and the need of 
implementation of the Quality Assurance (QA) programme and the Quality Control 
(QC) system. Within this scope, the QA procedures were introduced. Since this 
program comprises both the planning and running of systematic procedures to 
ensure an adequate conﬁdence level in the facility’s performance, critical points of 
the process were identiﬁed and reviewed. If “non-conformities” were identiﬁed (e.g. 
malfunctions, incorrect materials, tools, equipments, procedures, information and 
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lack of personnel training), corrective actions were established. The QA elements 
also include a documentation control (codiﬁcation), record system’s establishment, 
batch traceability, inspection and testing.
In attaining QC, actions were implemented that provided means to control and 
measure the process or facility characteristics in accordance with the established 
requirements of the QA programme. In this speciﬁc case a process monitoring and 
control software was employed. CHIP, S.A. is establishing the certiﬁcation for the EN 
ISO 13485:2003 “Quality Management Standard for Medical Devices” to be conﬁrmed 
by external audits.
Sterilization/Disinfection of products, from the line production up to the end of 
process
There is a strict connection between the irradiator operator and device manufacturer 
to achieve quality. The irradiator operator has to ensure that the irradiation process 
and delivered Dose are appropriately, adequately and correctly performed with 
quality assurance procedures. On the other hand, the device manufacturer has the 
responsibility to ensure that his product is safe and “sterilized”. This close relation 
to assure product qualiﬁcation is schematized in Figure 3.
Licensing UTR has brought the attention to Quality
issues and the need of implementation of the Quality
Assurance (QA) programme and the Quality Control (QC)
system. Within this scope, the QA procedures were introduced.
Since this program comprises both the planning and running
of systematic procedures to ensure an adequate confidence
level in the facility’s performance, critical points of the
process were identified and reviewed. If “non-conformities”
were identified (e.g. malfunctions, incorrect materials, tools,
equipments, procedures, information and lack of personnel
training), corrective actions were established. The QA
elements also include a documentation control (codification),
record system’s establishment, batch traceability, inspection
and testing.
In attaining QC, actions were implemented that
provided means to control and measure the process or facility
characteristics in accordance with the established
requirements of the QA programme. In this specific case a
process monitoring and control software was employed. CHIP,
S.A. is establishing the certification for the EN ISO
13485:2003 “Quality Management Standard for Medical
Devices” to be confirmed by external audits.
III. STERILIZATION/DISINFECTION OF PRODUCTS, FROM THE
LINE PRODUCTION UP TO THE END OF PROCESS
There is a strict connection between the irradiator
operator and device manufacturer to achieve quality. The
irradiator operator has to ensure that the irradiation process
and delivered Dose are appropriately, adequately and correctly
performed with quality assurance procedures. On the other
hand, the device manufacturer has the responsibility to ensure
that his product is safe and “sterilized”. This close relation to
assure product qualification is schematized in Figure 3.
Fig. 3. Diagram of sterilized product qualification.
In order to accomplish the sterilization level planned
for the product, it is necessary to perform several previous
studies in/on the product to develop techniques that validate
the irradiation process. The validation of a process consists in
tested and documented protocols that guarantee not only the
efficiency of the irradiation process but also the function
preservation of the product to be sterilized or decontaminated
by ionizing radiation.
The number and type of microorganisms present in a
product is known as the product’s bioburden and it is the
result from contaminations either from the raw materials or
from the production line: equipments, environment, personnel
and the final product unit (collection of products or
components within a primary package). The determination of
the bioburden of a product will allow an estimation of the
minimal dose (Dmin) to attain sterilization.
Nowadays, the generally accepted target for
sterilization processes must assure that the probability of
finding a non sterile unit is less than one in one million. That
is, the whole process will provide a Sterility Assurance Level
(SAL) equal or better than 10-6 [13], [14]. This survival
probability is represented by the following mathematical
model, Equation 1,
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Eq. 1
in which fi is the frequency of contamination classes, Ni is the
centre contamination class, Dj is the resistance of the
contaminant microorganisms, Pj is the occurrence probability
of Dj and D is the absorbed dose. This model is not as
conservative as the Method 1 of EN ISO 11137:2006 [15,16,
17], since is not limited to the product average bioburden and
resistance. Instead, it considers the frequency of bioburden
subdivided into contamination classes and the several
resistances of the contaminants microorganisms. Most of the
contamination sources impart in/on the products a large range
number of contaminations. Consequently, this model could fit
better to the experimental results obtained from a “real”
production line.
The selection of a sterilization dose can be done by
different approaches. It can be calculated either from the
number of viable microorganisms determinations or the
information obtained by incremental dose, or by selection of
the sterilization dose of 25 kGy (corroboration of the
suitability of this dose is required) [15,16,17].
One of the critical procedures in establishing or
auditing the sterilization dose (bioburden determination or in
the performance of a sterility test) is the sampling plan. As is
demonstrated the sterility tests could fail due to the low
representativity of samples. For example, for a sampling plan
with 10 units, there is a high probability of acceptance of lots
with a sterility assurance level that does not correspond to the
exigency described. However, increasing the sampling implies
a risk of rejection of lots that had attained the safety assurance
- Dmin Determination -- Dmax Determination -
Process Qualification
• Dose mapping in the product
Product Qualification
Instalation Qualification
• Tests and qualifications of all components
• Dosimetric systems calibration
Certification
• Analysis and documentation approval
MAINTENANCE AND CONTROL OF QUALITY (review)
Bioburden determination and its
resistance to the lethal agent
Material compatibility to �
radiation
• Control chart with alert and
rejection values
• Critical points detection
(production line)
Fig. 3. Diagram of sterilized product qualiﬁcation.
In order to accomplish the sterilization level planned for the product, it is necessary 
to perform several previous studies in/on the product to develop techniques that 
validate the irradiation process. The validation of a process consists in tested and 
documented protocols that guarantee not only the efﬁciency of the irradiation process 
but also the function preservation of the product to be sterilized or decontaminated 
by ionizing radiation.
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The number and type of microorganisms present in a product is known as the 
product’s bioburden and it is the result from contaminations either from the raw 
materials or from the production line: equipments, environment, personnel and the 
ﬁnal product unit (collection of products or components within a primary package). 
The determination of the bioburden of a product will allow an estimation of the 
minimal dose (Dmin) to attain sterilization. 
Nowadays, the generally accepted target for sterilization processes must assure that 
the probability of ﬁnding a non sterile unit is less than one in one million. That is, 
the whole process will provide a Sterility Assurance Level (SAL) equal or better than 
10-6 [13], [14]. This survival probability is represented by the following mathematical 
model, Equation 1,
Licensing UTR has brought the attention to Quality
issues and the need of implementation of the Quality
Assurance (QA) programme and the Quality Control (QC)
system. Within this scope, the QA procedures were introduced.
Since this program comprises both the planning and running
of systematic procedures to ensure an adequate confidence
level in the facility’s performance, critical points of the
process were identified and reviewed. If “non-conformities”
were identified (e.g. malfunctions, incorrect materials, tools,
equipments, procedures, information and lack of personnel
training), corrective actions were established. The QA
elements also include a documentation control (codification),
record system’s establishment, batch traceability, inspection
and testing.
In attaining QC, actions were implemented that
provided means to control and measure the process or facility
characteristics in accordance with the established
requirements of the QA programme. In this specific case a
process monitoring and control software was employed. CHIP,
S.A. is establishing the certification for the EN ISO
13485:2003 “Quality Management Standard for Medical
Devices” to be confirmed by external audits.
III. STERILIZATION/DISINFECTION OF PRODUCTS, FROM THE
LINE PRODUCTION UP TO THE END OF PROCESS
There is a strict connection between the irradiator
operator and device manufacturer to achieve quality. The
irradiator operator has to ensure that the irradiation process
and delivered Dose are appropriately, adequately and correctly
performed with quality assurance procedures. On the other
hand, the device manufacturer has the responsibility to ensure
that his product is safe and “sterilized”. This close relation to
assure product qualification is schematized in Figure 3.
Fig. 3. Diagram of sterilized product qualification.
In order to accomplish the sterilization level planned
for the product, it is necessary to perform several previous
studies in/on the product to develop techniques that validate
the irradiation process. The validation of a process consists in
tested and documented protocols that guarantee not only the
efficiency of the irradiation process but also the function
preservation of the product to be sterilized or decontaminated
by ionizing radiation.
The number and type of microorganisms present in a
product is known as the product’s bioburden and it is the
result from contaminations either from the raw materials or
from the production line: equipments, environment, personnel
and the final product unit (collection of products or
components within a primary package). The determination of
the bioburden of a product will allow an estimation of the
minimal dose (Dmin) to attain sterilization.
Nowadays, the generally accepted target for
sterilization processes must assure that the probability of
finding a non sterile unit is less than one in one million. That
is, the whole process will provide a Sterility Assurance Level
(SAL) equal or better than 10-6 [13], [14]. This survival
probability is represented by the following mathematical
model, Equation 1,
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Eq. 1
in which fi is the frequency of contamination classes, Ni is the
centre contamination class, Dj is the resistance of the
contaminant microorganisms, Pj is the occurrence probability
of Dj and D is the absorbed dose. This model is not as
conservative as the Method 1 of EN ISO 11137:2006 [15,16,
17], since is not limited to the product average bioburden and
resistance. Instead, it considers the frequency of bioburden
subdivided into contamination classes and the several
resistances of the contaminants microorganisms. Most of the
contamination sources impart in/on the products a large range
number of contaminations. Consequently, this model could fit
better to the experimental results obtained from a “real”
production line.
The selection of a sterilization dose can be done by
different approaches. It can be calculated either from the
number of viable microorganisms determinations or the
information obtained by incremental dose, or by selection of
the sterilization dose of 25 kGy (corroboration of the
suitability of this dose is required) [15,16,17].
One of the critical procedures in establishing or
auditing the sterilization dose (bioburden determination or in
the performance of a sterility test) is the sampling plan. As is
demonstrated the sterility tests could fail due to the low
representativity of samples. For example, for a sampling plan
with 10 units, there is a high probability of acceptance of lots
with a sterility assurance level that does not correspond to the
exigency described. However, increasing the sampling implies
a risk of rejection of lots that had attained the safety assurance
- Dmin Determination -- Dmax Determination -
Process Qualification
• Dose mapping in the product
Product Qualification
Instalation Qualification
• Tests and qualifications of all components
• Dosimetric systems calibration
Certification
• Analysis and documentation approval
MAINTENANCE AND CONTROL OF QUALITY (review)
Bioburden determination and its
resistance to the lethal agent
Material compatibility to �
radiation
• Control chart with alert and
rejection values
• Critical points detection
(production line)
  
in which fi is the frequency of contamination classes, Ni is the centre contamination 
class, Dj is the resistance of the contaminant microorganisms, Pj is the occurrence 
probability of Dj and D is the absorbed dose. This model is not as conservative as 
the Method 1 of EN ISO 11137:2006 [15,16, 17], since is not limited to the product 
average bioburden and resistance. Instead, it considers the frequency of bioburden 
subdivided into contamination classes and the several resistances of the contaminants 
micro rganisms. Most of the contamination sources impart in/on the products a 
large range number f co ta inations. Consequently, this model could ﬁt better to 
the experimental results btained from a “real” production line.
The selection of a terilization dose can be done by different approaches. It can be 
calculated either from the number of viable microorganisms determinations or the 
information obtained by incremental dose, or by selection of the sterilization dose of 
25 kGy (corroboration of the suitability of this dose is required) [15,16,17].
One of the critical procedures in establishing or auditing the sterilization dose 
(bioburden determinati n or in the performance of a sterility test) is the sampling 
plan. As is demonstrated the sterility tests could fail due to the low representativity 
of samples. For example, for a sampling plan with 10 units, there is a high probability 
of acceptance of lots with a sterility assurance level that does not correspond to the 
exigency described. However, increasing the sampling implies a risk of rejection of 
lots that had attained the safety assurance level set, due to cross contamination in 
he microbiological procedure .
The number and types of contaminated microorganisms detected on and in a “to-be-
i ra iated” product are two key elements that contribute to dose-setting. Conversely, 
there are several f ctors on the prod ction line that could inﬂuence the bioburden/
contamination of the ﬁnal product unit, such as: production area, equipment, 
personnel and raw material.
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The introduction of corrective actions in production line based on bioburden evaluation 
(quantitative and qualitative) can effectively turn on the microbiological control in the 
line production more reproducible and with lower contamination as it can be observed 
in the frequency of contamination values before and after corrections of the critical 
points. After corrective actions, the initial contamination classes’ frequency (N0/g) 
shifted to a normal distribution and the number of the highest contamination class 
(categories N0/g) was reduced from 1100 to 500 colony forming units/g (N0/g).
The statistical analysis of the bioburden results could also bring some information 
about line production good manufacturing practices. Once more, picking up the 
surgical dressing example, the median bioburden deviation was higher intra-batch 
than inter batches.
 Consequently, the reduction of the sterilization dose was achieved and the QA and 
QC were implemented. Another example with three industries of health care products 
is demonstrated in Figure 4.
level set, due to cross contamination in the microbiological
procedures.
The number and types of contaminated
microorganisms detected on and in a “to-be-irradiated”
product are two key elements that contribute to dose-setting.
Conversely, there are several factors on the production line
that could influence the bioburden/contamination of the final
product unit, such as: production area, equipment, personnel
and raw material.
The introduction of corrective actions in production
line based on bioburden evaluation (quantitative and
qualitative) can effectively turn on the microbiological control
in the line production more reproducible and with lower
contamination as it can be observed in the frequency of
contamination values before and after corrections of the
critical points. After corrective actions, the initial
contamination classes’ frequency (N0/g) shifted to a normal
distribution and the number of the highest contamination class
(categories N0/g) was reduced from 1100 to 500 colony
forming units/g (N0/g).
The statistical analysis of the bioburden results could
also bring some information about line production good
manufacturing practices. Once more, picking up the surgical
dressing example, the median bioburden deviation was higher
intra-batch than inter batches.
Consequently, the reduction of the sterilization dose
was achieved and the QA and QC were implemented. Another
example with three industries of health care products is
demonstrated in Figure 4.
Fig. 4. Sterilization Doses (Dmin) reductions in health care products. Example
of a frequency distribution shifting of the initial contamination classes (N0/g)
(a) before and (b) after corrective action in line production.
Nowadays, apart from working closely with Industries
to develop and validate the sterilization protocols, the research
Group is applying knowledge and expertise in the new
applications of ionizing radiation in different areas such as: 1)
sterilization of new materials for which the Dmin/Dmax ratio is
an important parameter [18], [19], [20] ; 2) desinfestation and
preservation of art objects 3) wastewater treatment, which
overall results point out the advantages of the ionizing
radiation use of as a complement technology to conventional
treatment [21] 4) food irradiation as a clean and safety
technology to extend shelf life and preserve health damages
[22].
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action in line production.
Nowadays, apart from working closely with Industries to develop and validate the 
sterilization protocols, the research Group is applying knowledge and expertise in the 
new applications of ionizing radiation in different areas such as: 1) sterilization of new 
materials for which the Dmin/Dmax ratio is an important parameter [18], [19], [20] ; 2) 
desinfestation and preservation of art objects 3) wastewater treatment, which overall 
results oint out the advantages of the i nizi g radiation us  of as a complement 
technology to c nventional treatment [21] 4) food irradiation as a clean and safety 
technology to extend shelf life and preserve health damages [22].
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